Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with glucocorticoids): evaluation report

01.  NICE’s response to comments on the Appraisal Consultation Document (ACD)

02. Consultee comments on the ACD - Roche Products

03.  Consultee comments on the ACD - Vasculitis UK

04.  Clinical expert comments on the ACD – Harper and Lanyon et al

05.  Public comments on the ACD received via the NICE website

06.  Illustrative analyses conducted by the School of Health and Related research (ScHARR)

Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.

* Users of Google chrome should click the link below and then click the small PDF icon in the far right of the address bar to successfully access this document *

This page was last updated: 23 January 2014